TY - JOUR
KW - Analgesics, Opioid/adverse effects
KW - Canada/epidemiology
KW - Drug Prescriptions/standards
KW - Epidemics/prevention & control
KW - Humans
KW - Opioid-Related Disorders/epidemiology/prevention & control
KW - Pain Management/adverse effects/methods
KW - Pain, Postoperative/drug therapy/etiology
KW - Practice Guidelines as Topic
KW - Practice Patterns, Physicians'/standards
KW - Reconstructive Surgical Procedures/adverse effects
KW - Surgery, Plastic/organization & administration/standards
KW - United States/epidemiology
AU - A. M. Q. Wang
AU - H. Retrouvey
AU - K. R. Wanzel
A1 - 
AB - The opioid epidemic has been a growing public health threat in the United States and Canada for the past 30 years, with alarming and steadily increasing opioid-related mortality rates. Originating with well-intentioned efforts by physicians to relieve pain and suffering in their patients, the source of the opioid epidemic and much of its ammunition continues to be the sales of legally produced pharmaceutical opioids. Although surgeons are increasingly recognizing the important role they can play in mitigating this crisis, the recognition and evaluation of the opioid epidemic in plastic surgery has been lacking. The authors identified several aspects of plastic surgery that make judicious prescription of opioids in this field uniquely complex, including high variability of cases managed, large volume of ambulatory procedures, and frequent involvement in collaborative care with other surgical specialties. Additional research in plastic surgery is needed to both increase current knowledge of opioid prescribing practices and provide evidence for recommendations that can successfully combat the opioid epidemic.
AD - Toronto, Ontario, Canada From the Faculty of Medicine and the Division of Plastic and Reconstructive Surgery, University of Toronto; and St. Joseph's Health Centre, Toronto, Ontario, Canada.
BT - Plastic and Reconstructive Surgery
C5 - Opioids & Substance Use
CP - 5
CY - United States
DO - 10.1097/PRS.0000000000004332
IS - 5
JF - Plastic and Reconstructive Surgery
M1 - Journal Article
N2 - The opioid epidemic has been a growing public health threat in the United States and Canada for the past 30 years, with alarming and steadily increasing opioid-related mortality rates. Originating with well-intentioned efforts by physicians to relieve pain and suffering in their patients, the source of the opioid epidemic and much of its ammunition continues to be the sales of legally produced pharmaceutical opioids. Although surgeons are increasingly recognizing the important role they can play in mitigating this crisis, the recognition and evaluation of the opioid epidemic in plastic surgery has been lacking. The authors identified several aspects of plastic surgery that make judicious prescription of opioids in this field uniquely complex, including high variability of cases managed, large volume of ambulatory procedures, and frequent involvement in collaborative care with other surgical specialties. Additional research in plastic surgery is needed to both increase current knowledge of opioid prescribing practices and provide evidence for recommendations that can successfully combat the opioid epidemic.
PP - United States
PY - 2018
SN - 1529-4242; 0032-1052
SP - 1295
EP - 1301
EP - 
T1 - Addressing the Opioid Epidemic: A Review of the Role of Plastic Surgery
T2 - Plastic and Reconstructive Surgery
TI - Addressing the Opioid Epidemic: A Review of the Role of Plastic Surgery
U1 - Opioids & Substance Use
U2 - 29697632
U3 - 10.1097/PRS.0000000000004332
VL - 141
VO - 1529-4242; 0032-1052
Y1 - 2018
Y2 - May
ER -